CIK 0001368514 · Large accelerated filer
ADMA BIOLOGICS, INC.
Sign in to watch- Ticker
- ADMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562590442
- Phone
- (201) 478-5552
- Business address
- C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
- Former names
- R&R ACQUISITION VI, INC
- 4 Open-market sale Director sold 10,000 shares at $21.31 ($213,100)
- 144 Insider Sale of Securities
- 8-K Event Shareholder vote results
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 9,000 shares at an average $20.29 ($182,636)
- 144 Insider Sale of Securities
- 4 Planned sale President and CEO sold 21,000 shares at $19.45 ($408,450)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Other events
- 4 Planned sale President and CEO sold 21,000 shares at $21.46 ($450,660)
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Shares withheld for taxes COO and SVP, Compliance gave up 18,920 shares (to pay taxes)
- 4 Planned sale President and CEO sold 21,000 shares at $18.92 ($397,320)
- 144 Insider Sale of Securities
Page 5 of 50 · 1,000 filings